Induction of tissue transglutaminase in the trabecular meshwork by TGF- β1 and TGF-β2

Investigative Ophthalmology and Visual Science

Volumn 41, Issue 8, 2000, Pages 2229-2238

  Welge Lüßen, Ulrich ^a   May, Chr Albrecht ^a   Lütjen Drecoll, Elke ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CADAVERINE; DEXAMETHASONE; FIBRONECTIN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2;

AQUEOUS HUMOR; ARTICLE; CROSS LINKING; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; GLAUCOMA; INTRAOCULAR PRESSURE ABNORMALITY; NORTHERN BLOTTING; POLYMERIZATION; PRIORITY JOURNAL; TISSUE INDUCTION; TRABECULAR MESHWORK; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; CADAVERINE; CELLS, CULTURED; CHILD; DEXAMETHASONE; ENZYME INDUCTION; FIBRONECTINS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GLUCOCORTICOIDS; HUMANS; MIDDLE AGED; RNA, MESSENGER; TRABECULAR MESHWORK; TRANSFORMING GROWTH FACTOR BETA; TRANSGLUTAMINASES;

EID: 0033924190     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (69)

1. Rohen JW, Witmer R. Electron microscopic studies on the trabecular meshwork in glaucoma simplex. Albrecht von Graefes Arch Klin Exp Ophthalmol. 1972;183:251-266.
2. Lütjen-Drecoll E. Functional morphology of the trabecular meshwork in primate eyes. Prog Ret Eye Res. 1998;18:91-119.
3. Lütjen-Drecoll E, Futa R, Rohen JW. Ultrahistochemical studies on tangential sections of the trabecular meshwork in normal and glaucomatous eyes. Invest Ophthalmol Vis Sci. 1981;21:563-573.
4. Rohen JW, Futa R, Lütjen-Drecoll E. The fine structure of the cribriform meshwork in normal and glaucomatous eyes as seen in tangential sections. Invest Ophthalmol Vis Sci. 1981;21:574-585.
5. Lütjen-Drecoll E, Shimizu T, Rohrbach M, Rohen JW. Quantitative analysis of "plaque material" in the inner and outer wall of Schlemm's canal in normal and glaucomatous eyes. Exp Eye Res. 1986;42:443-455.
6. Lütjen-Drecoll E, Rohen JW. Morphology of aqueous outflow pathways in normal and glaucomatous eyes. In: Ritch R, Shields MB, Krupin T, eds. The Glaucomas. Volume 1, 2nd ed. St. Louis: Mosby Year Book; 1996:89-124.
7. Acott TS. Trabecular extracellular matrix regulation. In: Drance SM, Van Buskirk EM, Neufeld AH, eds. Pharmacology of Glaucoma. Baltimore: Williams & Wilkins; 1992:125-157.
8. Acott TS. Biochemistry of aqueous humor outflow. In: Kaufman PL, Mittag TW, eds. Textbook of Ophthalmology. Volume 7. London: Mosby; 1994:1.47-41.78.
9. Acott TS, Wirtz MK. Biochemistry' of aqueous outflow. In Ritch R, Shields MB, Krupin T, eds. The Glaucomas. Volume 1, 2nd ed. St. Louis: Mosby Year Book; 1996:281-305.
10. Murphy GC, Johnson M, Alvarado JA. Juxtacanicular tissue in pigmentary and primary open angle glaucoma. Arch Ophthalmol. 1992;110:1779-1785.
11. Knepper PA, Goossens W, Hvizd M, Palmberg PF. Glycosaminoglycans of the human trabecular meshwork in primary open-angle glaucoma. Invest Ophthalmol Vis Sci. 1996;37:1360-1367.
12. Knepper PA, Goossens W, Palmberg PF. Glycosaminoglycan stratification of the juxtacanicular tissue in normal and primary open-angle glaucoma. Invest Ophthalmol Vis Sci. 1996;37:2414-2425.
13. Alexander JP, Samples JR, Van Buskirk EM, Acott TS. Expression of matrix metalloproteinases and inhibitor by human trabecular meshwork. Invest Ophthalmol Vis Sci. 1991;32:172-180.
14. Samples JR, Alexander JP, Acott TS. Regulation of the levels of human trabecular matrix metalloproteinases and inhibitor by interleukin-1 and dexamethasone. Invest Ophthalmol Vis Sci. 1993; 34:3386-3395.
15. Bradley JMB, Vranka J, Colvis CM, et al. Effect of matrix metalloproteinases activity on outflow in perfused human organ culture. Invest Ophthalmol Vis Sci. 1998;39:2649-2658.
16. Folk JE, Finlayson JS. The ∈-(γ-glutamyl) lysine crosslink and the catalytic role of transglutaminases. Adv Protein Chem. 1977;31:1-133
17. Folk JE. Transglutaminases. Annu Rev Biochem. 1980;49:517-531.
18. Fesus L, Thomazy V, Autuori F, Ceru MP, Tarcsa E, Piacentini M. Apoptotic hepatocytes become insoluble in detergents and chaotropic agents as a result of transglutaminase action. FEBS Lett. 1989;245:150-154.
19. Fesus L, Davies PJA, Piacentini M. Apoptosis-molecular mechanisms in programmed cell death. Eur J Cell Biol. 1991;56:170-177.
20. Lorand L, Conrad SM. Transglutaminase. Mol Cell Biochem. 1984; 58:9-35.
21. Rice RH, Green H. The cornified envelope of terminally differentiated human epidermal keratinocytes consists of cross linked protein. Cell. 1977;11:417-422.
22. Greenberg CS, Birckbichler PJ, Rice RH. Transglutaminases: multifunctional crosslinking enzymes that stabilize tissues. FASEB J. 1991;5:3071-3077.
23. Aeschlimann D, Paulsson M. Cross-linking of laminin-nidogen complexes by tissue transglutaminase. A novel mechanism for basement membrane stabilization. J Biol Chem. 1991;266:15308-15317.
24. Aeschlimann D, Wetterwald A, Fleisch H, Paulsson M. Expression of tissue transglutaminase in skeletal tissues correlates with events of terminal differentiation of chondrocytes. J Cell Biol. 1993;120: 1461-1470.
25. Thomazy V, Fesus L. Differential expression of tissue transglutaminase in human cells. Cell Tissue Res. 1989;225:215-224.
26. Cai D, Ben T, De Luca LM. Retinoids induce tissue transglutaminase in NIH-3T3 cells. Biochem Biophys Res Commun. 1991;175: 1119-1124.
27. Sane DC, Moser TL, Pippen AM, Parker CJ, Achyuthan KE, Greenberg CS. Vitronectin is a substrate for transglutaminases. Biochem Biophys Res Commun. 1988;157:115-120.
28. c-catalyzed crosslinking of laminin-nidogen complexes. J Biol Chem. 1992; 267:11316-11321.
29. Bowness JM, Folk JE, Timpl R. Identification of a substrate site for liver transglutaminase on the aminopropeptide of type III collage. J Biol Chem. 1987;262:1022-1024.
30. Murphy CG, Yun AJ, Newsome DA, Alvarado JA. Localization of extracellular proteins of the human trabecular meshwork by indirect immunofluorescence. Am J Ophthalmol. 1987;104:33-43.
31. Tengroth B, Rehnberg M, Amitzboll T. A comparative analysis of the collagen type and distribution in the trabecular meshwork, sclera, lamina cribrosa and the optic nerve in the human eye. Acta Opthalmol Suppl. 1985;173:91-93.
32. Dietlein TS, Jacobi PC, Paulsson M, Smyth N, Kriegelstein GK. Laminin heterogeneity around Schlemm's canal in normal humans and glaucoma patients. Ophthalmic Res. 1998;30:380-7.
33. Tripathi RC, Li J, Chan WFA, Tripathi BJ. Aqueous humor in glaucomatous eyes contains an increased level of TGF-β. Exp Eye Res. 1994;59:723-728.
34. Grehn F, Welge-Lüßen U, Picht G, Lütjen-Drecoll E. TGF-β2 and glaucoma: implications for therapy [ICER-Abstract]. Exp Eye Res. 1998;67:159.
35. Johnson DH, Gottanka J, Flügel C, Hoffmann F, Futa R, Lütjen-Drecoll E. Ultrastructural changes in the trabecular meshwork of human eyes treated with corticosteroids. Arch Ophthalmol. 1997; 115:375-383.
36. Babihayev MA, Brodskaya MW. Fibronectin detection in drainage outflow system of human eyes in ageing and progression of open angle glaucoma. Mech Ageing Dev. 1989;47:145-57.
37. Siegner A, May CA, Welge-Lüßen U, Bloemendal H, Lütjen-Drecoll E. αB-crystallin in the primate ciliary muscle and trabecular meshwork. Eur J Cell Biol. 1996;71:165-169.
38. Welge-Lüßen U, Eichhorn M, Bloemendal H, Lütjen-Drecoll E. Classification of human scierai spur cells in monolayer culture. Eur J Cell Biol. 1998;75:78-84.
39. Kornblihtt AR, Vide-Pedersen K, Baralle FE. Isolation and characterisation of cDNA clones for human and bovine fibronectins. Proc Natl Acad Sci USA.. 1983;80:3218-3222.
40. Gentile V, Saydak M, Chiocca EA, et al. Isolation and characterization of cDNA clones to mouse macrophage and human endothelial cell tissue transglutaminases. J Biol Chem. 1991;266:478-483.
41. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680-685.
42. Jones RA, Nicholas B, Mian S, Davies PJA, Griffin M. Reduced expression of tissue transglutaminase in a human endothelial cell line leads to changes in cell spreading, cell adhesion and reduced polymerisation of fibronectin. J Cell Sci. 1997;110:2461-2472.
43. Lorand L, Hsu LKH, Siefring GE Jr, Rafferty NS. Lens transglutaminase and cataract formation. Proc Natl Acad Sci USA.. 1981;78: 1356-1360.
44. Gentile V, Thomazy V, Piacentini M, Fesus L, Davies PJA. Expression of tissue transglutaminase in Balb-C 3T3 fibroblasts: effects on cellular morphology and adhesion. J Cell Biol. 1992;119:463-474.
45. Johnson TS, Knight CRL, El-Alaoui S, et al. Transfection of tissue transglutaminase into a highly malignant hamster fibrosarcoma leads to reduced incidence of primary tumour growth. Oncogene. 1994;9:2935-2942.
46. Verderio E, Nicholas B, Gross S, Griffin M Regulated expression of tissue transglutaminase in swiss 3T3 fibroblasts: effects on the processing of fibronectin, cell attachment, and cell death. Exp Cell Res. 1998;239:119-138.
47. Griffin M, Smith LL, Wynne J. Changes in transglutaminase activity in an experimental model of pulmonary fibrosis induced by paraquat. Br Exp Pathol. 1979;60:653-661.
48. Bowness JM, Tarr AH, Wiebe RI. Transglutaminase-catalysed crosslinking: a potential mechanism for the interaction of fibrinogen, low density lipoprotein and arterial type III procollagen. Thromb Res. 1989;54:357-367.
49. Bowness JM, Tarr AH. Lipoprotein binding of crosslinked type III collagen aminopropeptide and fractions of its antigen in blood. Biochem Biophys Res Commun. 1990;170:519-524.
50. Bowness JM, Venditti M, Tarr AH, Taylor JR. Increase in epsilon (gamma-glutamyl) lysine crosslinks in atherosclerotic aortas. Atherosclerosis. 1994;111:247-253.
51. Selkoe DJ, Abraham C, Ihara Y. Brain transglutaminase: in vitro crosslinking of human neurofilament proteins into insoluble polymers. Proc Natl Acad Sci USA.. 1982;79:6070-6074.
52. Dudek SM, Johnson GJ. Transglutaminase catalyzes the formation of sodium dodecyl sulfate-insoluble, Alz-50-reactive polymers of tau. J Neurochem. 1993;62:1159-1162.
53. Johnson TS, Griffin M, Thomas GL, et al. The role of transglutaminase in the rat subtotal nephrectomy model of renal fibrosis. J Clin Invest. 1997;99:2950-2960.
54. Jetten AM, Shirley JE, Stoner G. Regulation of proliferation and differentiation of respiratory-tract epithelial cells by TGF-β. Exp Cell Res. 1986;167:539-549.
55. George MD, Vollberg TM, Floyd EE, Stein JP, Jetten AM. Regulation of transglutaminase type II by transforming growth factor-beta in normal and transformed human epidermal keratinocytes. J Biol Chem. 1990;265:11098-11104.
56. Fukuda K, Kojiro M, Chiu JF. Differential regulation of tissue transglutaminase in rat hepatoma cell lines McA-RH7777 and McARH8994: relation to growth rate and cell death. J Cell Biochem. 1994;54:67-77.
57. Davies PJA, Murtaugh MP, Moore WT Jr, Johnson GS, Lucas D. Retinoic acid-induced expression of tissue transglutaminase in human promyelocytic leukemia (HL-60) cells. J Biol Chem. 1985; 260:5166-5174.
58. Moore WT Jr, Murtaugh MP, Davies PJA Retinoic acid-induced expression of tissue transglutaminase in mouse peritoneal macrophages. J Biol Cbem. 1984;259:12794-12802.
59. Chiocca EA, Davies PJA, Stein JP. The molecular basis of retinoic acid action: transcriptional regulation of tissue transglutaminase gene expression in macrophages. J Biol Chem. 1988;263:11584-11595.
60. Birckbichler PJ, Orr GR, Patterson MK Jr, Conway E, Carter HA, Maxwell MD. Enhanced transglutaminase activity in transformed human lung fibroblast cells after exposure to sodium butyrate. Biochim Biophys Acta. 1983;763:27-34.
61. Hsu K-HL, Friedmann H. Dimethyl sulfoxide-induced transglutaminase activity in murine-derived Friend erythroleukemia cells. J Natl Cancer Inst. 1983;70:965-969.
62. Lorand L, Hsu LKH, Siefring GE Jr, Rafferty NS. Lens transglutaminase and cataract formation. Proc Natl Acad Sci USA. 1981;78: 1356-1360.
63. Zhang SR, Li SL, Abler A, Fu J, Tso MOM, Lam TT. Tissue transglutaminase in apoptosis of photoreceptor cells in rat retina. Invest Ophthalmol Vis Sci. 1996;37:1793-1799.
64. 2+-treated lens. Invest Ophthalmol Vis Sci. 1987;28:1218-1222.
65. Martinez J, Chalupowicz DG, Roush RK, Sheth A, Barsigian C. Transglutaminase-mediated processing of fibronectin by endothelial cell monolayers. Biochemistry. 1994;33:2538-2545.
66. Barsigian C, Stern AM, Martinez J. Tissue (type II) transglutaminase covalently incorporates itself, fibrinogen, or fibronectin into high molecular weight complexes on the extracellular surface of isolated hepatocytes. Use of 2-[(2-oxopropyl)thio] imidazolium derivatives as cellular transglutaminase inactivators. J Biol Chem. 1991; 266:22501-22509.
67. Kojima S, Nara K, Rifkin DB. Requirement for transglutaminase in the activation of latent transforming growth factor-beta in bovine endothelial cells. J Cell Biol. 1993;121:439-448.
68. Kojima S, Vernooy R, Moscatelli D, Amanuma H, Rifkin DB. Lipopolysaccharide inhibits activation of latent transforming growth factor-beta in bovine endothelial cells. J Cell Physiol. 1995;163: 210-219.
69. Nunes I, Gleizes PE, Metz CN, Rifkin DB. Latent transforming growth factor-β binding protein domains involved in activation and transglutaminase dependent cross-linking of latent transforming growth factor-β. J Cell Biol. 1997;136:1151-1163.